Moss Genomics Inc. (MOSS.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 20 | 26 | 45 | 38 |
| Accounts receivable | -5 | -4 | -14 | -2 |
| Other Working Capital | 31 | 71 | -130 | 49 |
| Other Operating Activity | -357 | -129 | -616 | -654 |
| Operating Cash Flow | $-311 | $-36 | $-715 | $-568 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | N/A | N/A | 0 | -51 |
| Net Acquisitions | N/A | N/A | 0 | 46 |
| Investing Cash Flow | $N/A | $N/A | $0 | $-5 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | 4 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | 0 | -4 |
| Common Stock Issued | 350 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 30 | 45 | 1,263 |
| Financing Cash Flow | $354 | $30 | $45 | $1,260 |
| Beginning Cash Position | 12 | 18 | 688 | 1 |
| End Cash Position | 55 | 12 | 18 | 688 |
| Net Cash Flow | $43 | $-6 | $-670 | $687 |
| Free Cash Flow | ||||
| Operating Cash Flow | -311 | -36 | -715 | -568 |
| Capital Expenditure | N/A | N/A | N/A | -51 |
| Free Cash Flow | -311 | -36 | -715 | -618 |